Open | - |
Close | - |
Volume / Avg. | 0 / 676.216K |
Day Range | - - - |
52 Wk Range | 2.824 - 18.500 |
Market Cap | $14.146M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 36 |
Short Interest | 0.66% |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Evaxion Biotech (NASDAQ: EVAX) through any online brokerage.
Other companies in Evaxion Biotech’s space includes: Eterna Therapeutics (NASDAQ:ERNA), Immuron (NASDAQ:IMRN), Dominari Holdings (NASDAQ:DOMH), Addex Therapeutics (NASDAQ:ADXN) and Galera Therapeutics (NASDAQ:GRTX).
The latest price target for Evaxion Biotech (NASDAQ: EVAX) was reported by HC Wainwright & Co. on Monday, February 12, 2024. The analyst firm set a price target for 14.00 expecting EVAX to rise to within 12 months (a possible 376.19% upside). 3 analyst firms have reported ratings in the last year.
The stock price for Evaxion Biotech (NASDAQ: EVAX) is $2.94 last updated March 14, 2024 at 5:48 PM EDT.
There are no upcoming dividends for Evaxion Biotech.
Evaxion Biotech’s Q1 earnings are confirmed for Wednesday, May 29, 2024.
There is no upcoming split for Evaxion Biotech.
Evaxion Biotech is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.